These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18984533)

  • 21. Etiological diagnosis, prognostic significance and role of electrophysiological study in patients with Brugada ECG and syncope.
    Giustetto C; Cerrato N; Ruffino E; Gribaudo E; Scrocco C; Barbonaglia L; Bianchi F; Bortnik M; Rossetti G; Carvalho P; Riccardi R; Castagno D; Anselmino M; Bergamasco L; Gaita F
    Int J Cardiol; 2017 Aug; 241():188-193. PubMed ID: 28606693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term prognosis of patients diagnosed with Brugada syndrome: Results from the FINGER Brugada Syndrome Registry.
    Probst V; Veltmann C; Eckardt L; Meregalli PG; Gaita F; Tan HL; Babuty D; Sacher F; Giustetto C; Schulze-Bahr E; Borggrefe M; Haissaguerre M; Mabo P; Le Marec H; Wolpert C; Wilde AA
    Circulation; 2010 Feb; 121(5):635-43. PubMed ID: 20100972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pilsicainide-induced Brugada-type ECG and ventricular arrhythmias originating from the left posterior fascicle in a case with Brugada syndrome associated with idiopathic left ventricular tachycardia.
    Ueyama T; Shimizu A; Esato M; Yoshiga Y; Sawa A; Suzuki S; Sugi N; Matsuzaki M
    Europace; 2008 Jan; 10(1):86-90. PubMed ID: 18037690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meta-Analysis on Risk Stratification of Asymptomatic Individuals With the Brugada Phenotype.
    Letsas KP; Liu T; Shao Q; Korantzopoulos P; Giannopoulos G; Vlachos K; Georgopoulos S; Trikas A; Efremidis M; Deftereos S; Sideris A
    Am J Cardiol; 2015 Jul; 116(1):98-103. PubMed ID: 25933735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case of asymptomatic Brugada syndrome with type 1 ECG pattern and cardiac arrest: an evaluation of the prognostic value of electrophysiologic study].
    Cetin M; Canbay A; Cetin ZG; Diker E
    Turk Kardiyol Dern Ars; 2010 Apr; 38(3):202-5. PubMed ID: 20675999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The full stomach test as a novel diagnostic technique for identifying patients at risk of Brugada syndrome.
    Ikeda T; Abe A; Yusu S; Nakamura K; Ishiguro H; Mera H; Yotsukura M; Yoshino H
    J Cardiovasc Electrophysiol; 2006 Jun; 17(6):602-7. PubMed ID: 16836706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cohort of Patients Referred for Brugada Syndrome Investigation in an Electrophysiology Service - 19-Year Registry.
    Warpechowski Neto S; Leiria TLL; Ley LLG; Ley ALG; Dutra LZ; Pires LM; Kruse ML; Lima GG
    Arq Bras Cardiol; 2018 Jul; 111(1):13-18. PubMed ID: 29898017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Longer repolarization in the epicardium at the right ventricular outflow tract causes type 1 electrocardiogram in patients with Brugada syndrome.
    Nagase S; Kusano KF; Morita H; Nishii N; Banba K; Watanabe A; Hiramatsu S; Nakamura K; Sakuragi S; Ohe T
    J Am Coll Cardiol; 2008 Mar; 51(12):1154-61. PubMed ID: 18355652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of early repolarization pattern in inferolateral leads in patients with Brugada syndrome.
    Letsas KP; Sacher F; Probst V; Weber R; Knecht S; Kalusche D; Haïssaguerre M; Arentz T
    Heart Rhythm; 2008 Dec; 5(12):1685-9. PubMed ID: 19084806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of untreatable ventricular arrhythmias during pharmacologic challenges with sodium channel blockers for suspected Brugada syndrome.
    Poli S; Toniolo M; Maiani M; Zanuttini D; Rebellato L; Vendramin I; Dametto E; Bernardi G; Bassi F; Napolitano C; Livi U; Proclemer A
    Europace; 2018 Feb; 20(2):234-242. PubMed ID: 28521022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of sodium-channel blockade on early repolarization in inferior/lateral leads in patients with idiopathic ventricular fibrillation and Brugada syndrome.
    Kawata H; Noda T; Yamada Y; Okamura H; Satomi K; Aiba T; Takaki H; Aihara N; Isobe M; Kamakura S; Shimizu W
    Heart Rhythm; 2012 Jan; 9(1):77-83. PubMed ID: 21855521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of early repolarization in inferolateral leads in Brugada patients with documented ventricular fibrillation: a novel risk factor for Brugada syndrome with ventricular fibrillation.
    Kawata H; Morita H; Yamada Y; Noda T; Satomi K; Aiba T; Isobe M; Nagase S; Nakamura K; Fukushima Kusano K; Ito H; Kamakura S; Shimizu W
    Heart Rhythm; 2013 Aug; 10(8):1161-8. PubMed ID: 23587501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is a drug-challenge test with propafenone adequate to exclude Brugada syndrome?
    Yildiz BS; Gungor H; Gul I; Bilgin M; Zoghi M; Akilli A
    Cardiovasc J Afr; 2013 Mar; 24(2):e4-6. PubMed ID: 23613002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective study on spontaneous fluctuations between diagnostic and non-diagnostic ECGs in Brugada syndrome: implications for correct phenotyping and risk stratification.
    Veltmann C; Schimpf R; Echternach C; Eckardt L; Kuschyk J; Streitner F; Spehl S; Borggrefe M; Wolpert C
    Eur Heart J; 2006 Nov; 27(21):2544-52. PubMed ID: 16952922
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk stratification in patients with Brugada syndrome without previous cardiac arrest – prognostic value of combined risk factors.
    Okamura H; Kamakura T; Morita H; Tokioka K; Nakajima I; Wada M; Ishibashi K; Miyamoto K; Noda T; Aiba T; Nishii N; Nagase S; Shimizu W; Yasuda S; Ogawa H; Kamakura S; Ito H; Ohe T; Kusano KF
    Circ J; 2015; 79(2):310-7. PubMed ID: 25428522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Life-threatening ventricular arrhythmias during ajmaline challenge in patients with Brugada syndrome: incidence, clinical features, and prognosis.
    Conte G; Sieira J; Sarkozy A; de Asmundis C; Di Giovanni G; Chierchia GB; Ciconte G; Levinstein M; Casado-Arroyo R; Baltogiannis G; Saenen J; Saitoh Y; Pappaert G; Brugada P
    Heart Rhythm; 2013 Dec; 10(12):1869-74. PubMed ID: 24055942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and electrocardiographic predictors of positive response to the intravenous sodium channel blockers in patients suspected of the Brugada syndrome.
    Shahrzad S; Khoramshahi M; Aslani A; Fazelifar AF; Haghjoo M
    Int J Cardiol; 2013 May; 165(2):285-90. PubMed ID: 21917337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ventricular arrhythmia during ajmaline challenge for the Brugada syndrome.
    Dobbels B; De Cleen D; Ector J
    Europace; 2016 Oct; 18(10):1501-1506. PubMed ID: 26941343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical aspects and prognosis of Brugada syndrome in children.
    Probst V; Denjoy I; Meregalli PG; Amirault JC; Sacher F; Mansourati J; Babuty D; Villain E; Victor J; Schott JJ; Lupoglazoff JM; Mabo P; Veltmann C; Jesel L; Chevalier P; Clur SA; Haissaguerre M; Wolpert C; Le Marec H; Wilde AA
    Circulation; 2007 Apr; 115(15):2042-8. PubMed ID: 17404158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The value of a family history of sudden death in patients with diagnostic type I Brugada ECG pattern.
    Sarkozy A; Sorgente A; Boussy T; Casado R; Paparella G; Capulzini L; Chierchia GB; Yazaki Y; De Asmundis C; Coomans D; Brugada J; Brugada P
    Eur Heart J; 2011 Sep; 32(17):2153-60. PubMed ID: 21727093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.